Informatie:
Fout:
ID
14142
Beschrijving
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01520818
Link
https://clinicaltrials.gov/show/NCT01520818
Trefwoorden
Versies (1)
- 31-03-16 31-03-16 -
Geüploaded op
31 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes NCT01520818
Eligibility Diabetes NCT01520818
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT01520818
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Type 1 or type 2 diabetes
Item
type 1 or type 2 diabetes
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0011860 (UMLS CUI [2])
Biphasic human insulin and insulin regime
Item
current treatment with bhi 30 twice daily as the only insulin therapy for at least 3 months, with or without combination with oral hypoglycaemic agents
boolean
C1562202 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
C0557978 (UMLS CUI [1,2])
Body mass index
Item
body mass index (bmi) maximum 40.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Substance use disorder
Item
history of drug or alcohol dependence
boolean
C0038586 (UMLS CUI [1])
Hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
Renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
Cardiac disease
Item
cardiac disease
boolean
C0018799 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
daily insulin dose
Item
total daily insulin dose at least 1.80 iu/kg
boolean
C2348070 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
C0557978 (UMLS CUI [1,2])